Clinical Trials Directory

Trials / Suspended

SuspendedNCT00967967

Validation of the Rhinitis Control Scoring System (RCSS)

Validation of a Rhinitis Control Tool : the Rhinitis Control Scoring System (RCSS)

Status
Suspended
Phase
N/A
Study type
Interventional
Enrollment
50 (estimated)
Sponsor
Laval University · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Not accepted

Summary

Many patients suffering from allergic rhinitis do not recognize or perceive their symptoms. Instruments have been developed to assess quality of life in rhinitis, asthma or both, but there is a need to develop validated tools or methods to assess rhinitis control among rhinitis and/or asthmatic patients. The aim of this study is to assess the discriminative and evaluative properties of the RCSS in asthmatic patients with allergic rhinitis.

Detailed description

Allergic asthmatic subjects showing seasonal rhinitis symptoms will be recruited. The discriminative (internal consistency, cross sectional construct validity and reliability) and evaluative (responsiveness and longitudinal construct validity) properties of the RCSS will be evaluated as well as the relationship between rhinitis control and asthma control. RCSS will be completed at various time points during the seasonal allergic period.

Conditions

Interventions

TypeNameDescription
DRUGMedication Mometasone furoate and desloratadineOne month treatment with both drugs

Timeline

Start date
2009-03-01
Primary completion
2014-06-01
Completion
2014-09-01
First posted
2009-08-28
Last updated
2013-05-27

Locations

1 site across 1 country: Canada

Source: ClinicalTrials.gov record NCT00967967. Inclusion in this directory is not an endorsement.